Register today and receive more information, and a free trial coupon
Is CONCERTA® Right For My Child?
Proven Effective and Well Tolerated
Everyday activities can be a challenge when your child has ADHD. But making the decision to treat your child’s ADHD symptoms is an important first step. If your child has been diagnosed with ADHD, ask a healthcare professional how CONCERTA® can help your child manage ADHD symptoms.
Over 53 million prescriptions have been written for CONCERTA®. With more than 8 years of proven safety, CONCERTA® is the #1 prescribed ADHD medication by pediatricians. CONCERTA® has been proven well tolerated in clinical studies of over 2,700 children and adolescents.
Methylphenidate, the medication in CONCERTA®, is recommended among first-line therapies by the American Academy of Pediatrics as part of a total treatment program for ADHD. Part of this includes a team of people focused on helping your child like family members, caregivers, teachers, and your child’s healthcare professional. This treatment approach may also include behavioral therapy.
In a study, teachers reported that children taking CONCERTA® showed improvement in ADHD symptoms as measured in areas such as focusing better, paying attention better, and completing projects that they started.
In a survey, parents reported that CONCERTA® helped their child get along better with others. Ninety-one percent said their child gets into less trouble and fewer arguments at home. And 96% of parents said their child gets into trouble less often at school.*
CONCERTA® has a low incidence of side effects. In clinical studies, less than 3% of children and adolescents experienced insomnia and less than 1% experienced a loss of appetite or moodiness. The most common adverse reaction was upper abdominal pain (5.9%). Learn more about the safety of CONCERTA®
If your child has been diagnosed with ADHD, ask his or her healthcare professional how treatment with CONCERTA® can help your child manage the everyday challenges of ADHD.
*This survey was conducted online within the United States by Harris Interactive on behalf of McNeil Pediatrics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, between May 21 and June 2, 2008, among 150 adults who had a child aged 6–17 who had been diagnosed with ADHD and was taking CONCERTA® for more than 3 months at that time.
Full US Prescribing Information and Medication Guide
Visit concerta.net for more information about CONCERTA®.
CONCERTA® is a prescription product approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.
IMPORTANT SAFETY INFORMATION
Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.
Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.
CONCERTA® should not be taken by patients who have: allergies to methylphenidate or other ingredients in CONCERTA®; significant anxiety, tension, or agitation; glaucoma; tics, Tourette’s syndrome, or family history of Tourette’s syndrome; current or past use of monoamine oxidase inhibitor (MAOI); esophagus, stomach, or intestinal narrowing. Children under 6 years of age should not take CONCERTA®.
Abuse of methylphenidate may lead to dependence. Tell your healthcare professional if you or your child has had problems with alcohol or drugs; has had any heart problems, heart defects, high blood pressure, or a family history of these problems; has had depression, abnormal thoughts or visions, bipolar disorder, or seizure. Contact your healthcare professional immediately if you or your child: develops abnormal thinking or hallucinations, abnormal or extreme moods and/or excessive activity; or if aggressive behavior or hostility develops or worsens while taking CONCERTA®. Your child’s healthcare professional should check height and weight often and may interrupt CONCERTA® treatment if your child is not growing or gaining weight as expected.
Stimulants may impair the ability of the patient to operate potentially hazardous machinery or vehicles. Caution should be used accordingly until you are reasonably certain that CONCERTA® does not adversely affect your ability to engage in such activities.
The most common adverse reaction (>5%) reported in children and adolescents was upper abdominal pain. The most common adverse reactions (>10%) reported in adults were dry mouth, nausea, decreased appetite, headache, and insomnia.
CONCERTA® and OROS® are registered trademarks of ALZA Corporation.
© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2009
Questions or comments? Call 1-888-440-7903
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For information on free or discounted prescription medications, visit access2wellness.com or call 866-317-2775.
60CON09088